Experience with proprotein convertase subtilisin/kexine...

Atherosclerosis Supplements 2019 / 12 Vol. 40

Experience with proprotein convertase subtilisin/kexine type 9 inhibitors (PCSK9i) in patients undergoing lipoprotein apheresis

Tselmin, Sergey, Julius, Ulrich, Weinert, Nadine, Bornstein, Stefan R., Schatz, Ulrike
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
40
Journal:
Atherosclerosis Supplements
DOI:
10.1016/j.atherosclerosissup.2019.08.045
Date:
December, 2019
File:
PDF, 836 KB
2019
Conversion to is in progress
Conversion to is failed